|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
CH656884A5
(de)
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
|
ATE59289T1
(de)
|
1985-10-09 |
1991-01-15 |
Desitin Arzneimittel Gmbh |
Verfahren zur herstellung einer darreichungsund dosierungsform fuer arzneimittel-wirkstoffe, reagentien oder andere wirkstoffe.
|
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
|
US5538739A
(en)
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
|
CN1074923C
(zh)
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
|
WO2000035419A2
(en)
|
1998-12-17 |
2000-06-22 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
|
MXPA01012969A
(es)
|
1999-06-15 |
2003-10-14 |
Bristol Myers Squibb Pharma Co |
Gamma-carbolinas fusionadas de heterociclo sustituido.
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
PL366233A1
(en)
|
2000-12-20 |
2005-01-24 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
|
EP1919287A4
(en)
|
2005-08-23 |
2010-04-28 |
Intra Cellular Therapies Inc |
ORGANIC COMPOUNDS FOR TREATING A REDUCED DOPAMINE RECEPTOR SIGNALING ACTIVITY
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
KR102065319B1
(ko)
|
2007-03-12 |
2020-01-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
|
AU2009212065B2
(en)
|
2008-02-05 |
2014-03-20 |
Clera Inc. |
Compositions and methods for alleviating depression or improving cognition
|
|
JP5611846B2
(ja)
|
2008-03-12 |
2014-10-22 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
置換ヘテロ環縮合ガンマ−カルボリン類固体
|
|
CN105168219B
(zh)
|
2008-05-27 |
2018-11-20 |
细胞内治疗公司 |
用于睡眠障碍和其他疾病的方法和组合物
|
|
EP2560676B8
(en)
|
2010-04-22 |
2016-10-12 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
TWI582092B
(zh)
|
2010-07-28 |
2017-05-11 |
歌林達股份有限公司 |
順式－四氫－螺旋（環己烷－１,１’－吡啶［３,４－b］吲哚）－４－胺－衍生物
|
|
DE102010041942B4
(de)
|
2010-10-04 |
2013-01-17 |
Lear Corporation |
Bewegliche Kopfstützen für Fahrzeugsitze
|
|
CN105997521B
(zh)
|
2011-08-16 |
2018-12-25 |
株式会社东商 |
片剂分割装置
|
|
WO2013155504A1
(en)
|
2012-04-14 |
2013-10-17 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
SG11201501894VA
(en)
|
2012-09-14 |
2015-04-29 |
Abbvie Inc |
Tricyclic quinoline and quinoxaline derivatives
|
|
HUE053159T2
(hu)
|
2013-03-15 |
2021-06-28 |
Intra Cellular Therapies Inc |
Szerves vegyületek
|
|
CN105706016B
(zh)
|
2013-09-11 |
2019-07-19 |
欧力天工美国公司 |
用于时钟同步的系统、方法和移动设备
|
|
IL305990B2
(en)
|
2013-12-03 |
2025-12-01 |
Intra Cellular Therapies Inc |
Long-acting injectable composition comprising polymeric microspheres of heterocycle fused gamma-carboline compounds or a pharmaceutical composition for sustained or delayed release comprising the compounds and their use in the treatment of bipolar disorder i and/or bipolar ii disorder
|
|
RU2016143091A
(ru)
|
2014-04-04 |
2018-05-08 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
MX365969B
(es)
|
2014-04-04 |
2019-06-21 |
Intra Cellular Therapies Inc |
Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
|
|
WO2015191554A1
(en)
|
2014-06-09 |
2015-12-17 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
WO2017117514A1
(en)
|
2015-12-31 |
2017-07-06 |
Tung Roger D |
Deuterated iti-007
|
|
CN108883111B
(zh)
|
2016-01-26 |
2021-10-08 |
细胞内治疗公司 |
有机化合物
|
|
PL3407889T3
(pl)
*
|
2016-03-25 |
2021-11-22 |
Intra-Cellular Therapies, Inc. |
Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego
|
|
US20200392135A1
(en)
|
2016-03-25 |
2020-12-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
|
JP2019513143A
(ja)
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
新規塩類および結晶
|
|
EP4001281A1
(en)
|
2016-08-09 |
2022-05-25 |
Teva Pharmaceuticals International GmbH |
Solid state forms of lumateperone ditosylate salt and preparation thereof
|
|
US10906906B2
(en)
|
2016-12-29 |
2021-02-02 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
|
AU2018234931B2
(en)
|
2017-03-17 |
2022-05-26 |
Blackthorn Therapeutics, Inc. |
Kappa opioid receptor antagonists and products and methods related thereto
|
|
IL268970B2
(en)
|
2017-03-24 |
2023-12-01 |
Intra Cellular Therapies Inc |
Oral transmucosal formulations of substituted heterocycle fused gamma carbolines
|
|
JP7223742B2
(ja)
|
2017-07-26 |
2023-02-16 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
AU2019240226B2
(en)
|
2018-03-23 |
2024-11-28 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2019237037A1
(en)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
US20220160704A2
(en)
|
2018-08-08 |
2022-05-26 |
Torralva Medical Therapeutics Llc |
Compositions for opiate and opioid prevention and reversal, and methods of their use
|
|
WO2020132605A1
(en)
|
2018-12-21 |
2020-06-25 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US12195463B2
(en)
|
2018-12-21 |
2025-01-14 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10668097B1
(en)
|
2019-03-21 |
2020-06-02 |
Direct Digital, LLC |
Testosterone enhancing compositions and methods
|
|
EP3946345A4
(en)
|
2019-04-04 |
2023-01-04 |
Intra-Cellular Therapies, Inc. |
METHODS OF TREATMENT OF NEUROPATHIC PAIN
|
|
CA3139168A1
(en)
|
2019-05-07 |
2020-11-12 |
Nirsum Laboratories, Inc. |
Opioid receptor antagonist prodrugs
|